Status:
COMPLETED
Cohort Study on Patient Outcomes, Effectiveness and Cost-effectiveness of Intervention Programmes for DM/HT Patients
Lead Sponsor:
The University of Hong Kong
Conditions:
Hypertension
Diabetes Mellitus
Eligibility:
FEMALE
18+ years
Brief Summary
Objectives: To determine the outcome trajectories of patients with hypertension (HT) and/or diabetes mellitus (DM), and evaluate the long-term effectiveness and cost-effectiveness of the Risk Assessme...
Detailed Description
A naturalistic cohort study with a maximum follow-up period of 10 years, and retrospective extraction of relevant data from the HA clinical management system (CMS) database, designed as four sub-studi...
Eligibility Criteria
Inclusion
- (Trajectory study)
- All patients aged 18 years or above with a documented doctor-diagnosed DM or HT between 2006 and 2019.
- Documented management in the HA GOPC or FMC identified from the HA CM database between 2006 and 2019.
- (10-year CEA study on RAMP-DM)
- Documented diagnosis of DM without any known complications on or before September 2010
- Documented management in the HA GOPC and FMC identified from the HA CMS database between 2009 and 2019,
- Patients who attended the first RAMP-DM assessment between August 2009 to September 2010 for inclusion in the RAMP-DM cohort
- Patients who have never attended any RAMP-DM assessment between August 2009 to December 2019 for inclusion in the usual care only cohort
- (10-year CEA study on RAMP-HT)
- Documented diagnosis of HT without DM and any known complications on or before March 2013
- Documented management in the HA GOPC and FMC identified from the HA CMS database between 2011 and 2021,
- Patients who attended the first RAMP-HT assessment between October 2011 to March 2013 for inclusion in the RAMP-HT cohort
- Patients who have never attended any RAMP-HT assessment between October 2011 to December 2021 for inclusion in the usual care only cohort
- (5-year CEA study on PSCC)
- Documented diagnosis of DM without any known complications on or before August 2016
- Documented management in the HA GOPC and FMC identified from the HA CMS database between 2012 and 2021,
- Patients who attended the first RAMP-DM assessment between September 2012 to August 2016
- Patients who received the first PSCC call between September 2012 to August 2016 after the first RAMP-DM assessment for inclusion in the PSCC cohort
- Patients who have never received any PSCC services between September 2012 to December 2021 for inclusion in the RAMP only cohort
Exclusion
- (applicable to all sub-studies)
- Non-Chinese
- Patients with documented DM/HT-related complications diagnosed before the date of enrolment
- Medical specialist outpatient attendance before or within the first year of inclusion to study, to exclude subjects who might have developed complications before study enrolment
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT04302974
Start Date
August 1 2019
End Date
September 30 2024
Last Update
December 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Family Medicine & Primary Care, LKS Faculty of Medicine, University of Hong Kong
Hong Kong, Hong Kong, China